The preventive action of leflunomide on liver fibrosis and its mechanisms in mice
- VernacularTitle:来氟米特对实验性肝纤维化的预防作用及部分机制研究
- Author:
Yunfang ZHANG
;
Yong JIN
;
Jun LI
;
Hongwei YAO
;
Changyu LI
;
Shuyun XU
- Publication Type:Journal Article
- From:
Chinese Pharmacological Bulletin
2001;17(2):203-205
- CountryChina
- Language:Chinese
-
Abstract:
AIM To observe the preventive action of leflunomide (Lef) on CCl4-induced liver fibrosis and explore its mechanism. METHODS Model of liver fibrosis in mice was induced by subcutaneous injection of CCl4(20%). The levels of ALT、AST、NO in plasma and Hyp in liver tissue were determined by spectroscopy. The content of HA in plasma was determined by radioimmunoassay. RESULTS Pretreatment of Lef (4,12,36 mg·kg-1) significantly reduced the elevated levels of ALT、AST、NO in plasma and Hyp in liver tissue, Pathological examination suggested Lef has preventive action on experimental liver fibrosis with significance. CONCLUSION Lef has significantly preventive action on CCl4-induced liver fibrosis possibly mediated by reduction of NO.
